Rosabella Moringa Recall Lawsuit | 2026 Latest Updates

Ambrosia Brands, LLC voluntarily recalled specific lots of Rosabella Moringa Capsules, sold in 60-count bottles, over possible Salmonella contamination. The company announced the recall on February 13, 2026, covering 52 lot codes with 2027 expiration dates.

Because the outbreak strains resist many common antibiotics, consumers should check their bottles against the lot list right away and stop using any that match.

Affected capsules should be thrown away or returned to the place of purchase. The FDA closed the linked outbreak investigation on April 1, 2026, though the recall itself stays in effect because affected capsules have a long shelf life.

Latest Rosabella Moringa Recall Updates

April 1, 2026: FDA Marks Outbreak Investigation Complete

The FDA outbreak investigation into Rosabella Moringa Capsules was marked complete on April 1, 2026 [1]. The agency revised the case count to 10 illnesses across 8 states, with 3 hospitalizations and zero deaths.

A second strain, Salmonella Kentucky, joined Salmonella Newport, and the onset window widened to September 26, 2025, through January 8, 2026. Traceback pointed to one supplier, and an Indiana sample matched the strain by genetic sequencing.

March 1, 2026: Singapore Regulators Issue Consumer Notice

The Communicable Diseases Agency and Health Sciences Authority in Singapore issued a consumer notice on March 1, 2026 [2]. The notice told local buyers to stop consuming Rosabella Moringa Capsules right away.

Retailers pulled the product from local e-commerce listings soon after the notice went out. The agencies reported no Salmonella cases linked to the product in Singapore itself, though the product had reached that market through international sale.

February 19, 2026: FDA Updates International Distribution Details

The FDA updated its outbreak advisory on February 19, 2026, the same notice already cited above, to add international distribution details for Rosabella Moringa Capsules. The update confirmed that the February 13 recall covered both nationwide and international sales.

The advisory listed more than 70 countries that had received the product through direct online sales. That scope helped explain why regulators outside the United States, including Singapore, later took their own action.

February 13, 2026: Ambrosia Brands Announces Voluntary Recall

The FDA recall notice states that Ambrosia Brands, LLC announced a voluntary recall of Rosabella Moringa Capsule lots on February 13, 2026 [3]. The recall followed an FDA and CDC outbreak investigation. No total unit count was published.

At that point, 7 people across 7 states had reported illness, including 3 hospitalizations and no deaths. Reported illness onset ran from November 7, 2025, through January 8, 2026.

Which Rosabella Moringa Are Affected?

Rosabella Moringa Capsules, sold by Ambrosia Brands, LLC, are covered by the recall. Fifty-two separate lot codes are affected, though every recalled bottle shares the same packaging.

Check the following details on a bottle to see whether it falls under the recall:

• Rosabella Moringa Capsules in 60-count white plastic bottles with a green lid and label
• Lot codes in the 1356 SKU series, with either a -1 or -2 suffix
• Printed expiration dates that fall between March 2027 and November 2027 on the label
• A 7-digit lot code stamped directly above the expiration date on the bottle

The recall does not cover every Rosabella Moringa bottle on the market. Only bottles matching the SKU pattern and expiration-date range above are included, so consumers should compare both details before discarding or keeping a bottle.

Why Was Rosabella Moringa Recalled?

Rosabella Moringa Capsules were recalled because of possible contamination with Salmonella, according to the FDA’s recall notice. The outbreak strains resist most antibiotics normally used to treat a Salmonella infection, which limits treatment options for anyone who becomes ill.

An FDA and CDC investigation traced the contamination back to one moringa-powder supplier that fed into Ambrosia Brands’ production. Investigators also linked a household product sample to the outbreak strain through genetic testing, adding further evidence behind the recall decision.

The recall reason is the possible contamination itself, separate from the illnesses reported in connection with the outbreak. Ambrosia Brands pulled the affected lots once the FDA and CDC identified the shared supplier as the likely source.

Reported Incidents, Injuries, or Illnesses

The most recent FDA update reported 10 illnesses across 8 states linked to Rosabella Moringa Capsules, as of April 1, 2026. Three of those cases required hospitalization, and no deaths were reported.

At the initial February 13, 2026 announcement, the count stood at 7 illnesses across 7 states, with 3 hospitalizations and no deaths. The higher April figure reflects a wider investigation window that reached back to September 26, 2025.

These reports come from state and federal health officials who tracked cases tied to the outbreak strains. A reported illness is not by itself proof that a specific bottle caused a specific case.

What Should Consumers Do?

If you have Rosabella Moringa Capsules at home, take the following steps:

1. Check your bottle’s lot code and expiration date against the recalled range listed above.
2. Stop eating the capsules immediately if the lot code matches, and do not sell or give them away.
3. Throw the capsules away or return them to the place of purchase for a refund.
4. Clean and sanitize any containers or surfaces that touched the recalled capsules.
5. Watch for Salmonella symptoms, such as diarrhea, fever, and stomach cramps, usually appearing 12 to 72 hours after exposure.
6. Call a doctor right away if any of these symptoms appear after using the product.
7. Contact Ambrosia Brands at 914-768-1357, Monday through Friday from 9 a.m. to 4 p.m. Central time, with questions about the recall.
8. Report any illness or reaction to the FDA’s Industry and Consumer Assistance channel.

Other Recalls, Warnings, or International Actions

Singapore was the only country outside the United States where regulators took formal public action tied to this recall. Its health agencies acted after Rosabella Moringa Capsules reached that market through international online sales.

No other country’s health or safety agency issued a comparable public notice about this product, and no additional foreign class actions were found.

Legal Options

No lawsuit, class action, or multidistrict litigation over Rosabella Moringa Capsules has been filed. Court records and the federal docket for multidistrict cases were reviewed for this page. A recall does not automatically establish liability or eligibility for compensation.

Anyone who bought an affected lot of Rosabella Moringa Capsules and became ill, or needed medical care afterward, may want a legal review of their situation.

Because the FDA traced the contamination to a single supplier, a review of the specific facts is the only way to say whether a claim is possible.

Filing Deadlines

State law sets deadlines for bringing a legal claim connected to this recall, and the deadline that applies depends on where a person lives.

It also depends on when the illness, medical care, and diagnosis happened. Some states start counting from the date of diagnosis rather than the date of exposure.

Missing a filing deadline can end a claim, even one supported by strong facts. A prompt conversation with a lawyer is the best way to find out how much time remains.

Frequently Asked Questions

What Are the Symptoms of a Salmonella Infection?

The symptoms of a Salmonella infection include diarrhea, fever, and stomach cramps, usually lasting four to seven days. These symptoms can be more severe for children under five, older adults, and people with weakened immune systems, so they should seek care quickly if signs appear.

How Does the FDA Classify the Rosabella Moringa Recall?

The FDA classifies the Rosabella Moringa recall under its Foodborne Illness category on its recalls webpage, which groups it with other recalls tied to contamination risks in food products rather than drugs or medical devices.

Where Is Ambrosia Brands Located?

Ambrosia Brands is located in New York, NY, where the FDA recall notice lists the company’s headquarters. The notice names the company as the recalling firm responsible for notifying consumers and retailers.

Which States Reported Illnesses Linked to Rosabella Moringa?

The FDA’s most recent update on Rosabella Moringa lists reported illnesses in these states: Arizona, Florida, Iowa, Illinois, Indiana, Tennessee, Virginia, and Washington. That is one more state than the seven named in the original announcement.

Did Singapore Take Any Action on Rosabella Moringa?

Yes, Singapore’s health regulators acted on Rosabella Moringa Capsules, as described above. They also alerted the Health Supplements Industry Association Singapore, a step aimed at reaching sellers directly rather than only consumers.

Where Was Rosabella Moringa Sold Outside the United States?

Rosabella Moringa Capsules were sold in more than 70 countries outside the United States, including Canada, the United Kingdom, and Australia, according to the FDA’s international distribution details. Retailers also resold the product without authorization on sites such as eBay and Amazon, which never sold it directly.

References

1. https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-extensively-drug-resistant-salmonella-moringa-powder-february-2026
2. https://www.cda.gov.sg/news-and-events/consumers-advised-to-stop-consuming-rosabella-brand-moringa-powder-capsules-by-ambrosia-brands-llc/
3. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ambrosia-brands-llc-recalls-rosabella-moringa-capsules-because-possible-health-risk